Novo's CagriSema Delivered 25% Weight Loss in Women. Could It Help Turn Around the Beaten-Down Stock?
Its leading investigational drug demonstrated relatively high levels of weight loss in a late-stage clinical trial.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.